Bicycle Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCYC and other ETFs, options, and stocks.

About BCYC

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. 

CEO
Kevin Lee
CEOKevin Lee
Employees
284
Employees284
Headquarters
Cambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded
2009
Founded2009
Employees
284
Employees284

BCYC Key Statistics

Market cap
1.04B
Market cap1.04B
Price-Earnings ratio
-5.51
Price-Earnings ratio-5.51
Dividend yield
Dividend yield
Average volume
306.28K
Average volume306.28K
High today
$25.50
High today$25.50
Low today
$24.55
Low today$24.55
Open price
$25.33
Open price$25.33
Volume
266.72K
Volume266.72K
52 Week high
$28.91
52 Week high$28.91
52 Week low
$12.54
52 Week low$12.54

BCYC News

TipRanks 2d
Power Pedal: How Insider Voting Clout Could Sway Bicycle Therapeutics’ Future

Bicycle Therapeutics (BCYC) has disclosed a new risk, in the Share Price & Shareholder Rights category. Bicycle Therapeutics faces a significant business risk...

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.